CONSTITUENT REPORT
p-Cymene
p-Cymene is an aromatic monoterpene hydrocarbon found across many essential oils in the AromaForge archive, especially thyme, oregano, tea tree, frankincense, angelica root, and citrus-adjacent profiles. The strongest accessible evidence for the isolated molecule is not clinical efficacy but a combination of solid identity data, broad natural occurrence, fragrance use, harmonized chemical-hazard classification, and a modest preclinical literature on inflammatory signaling and oxidative-stress models. For archive purposes, it is best positioned as a common terpene marker with early mechanistic research rather than a stand-alone wellness claim.
Chemical identity and composition
PubChem lists p-cymene as CID 7463 with formula C10H14 and IUPAC name 1-methyl-4-propan-2-ylbenzene. ECHA's identity page cross-lists the same CAS and EC identifiers. In AromaForge oil files, p-cymene is repeatedly used as a meaningful secondary component or chemotype companion, especially in carvacrol/thymol-rich oils and selected resinous or cineole-rich materials.
Aroma and practical use
- Use the recorded citrus, terpenic, lemon, bergamot, woody-spicy, solvent-like, citrus-peel, mildly woody descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2012 study reported that p-cymene modulated cytokine production in vitro and in vivo under LPS-driven inflammatory conditions, supporting a preclinical immunomodulatory signal.
A 2012 study reported that p-cymene modulated cytokine production in vitro and in vivo under LPS-driven inflammatory conditions, supporting a preclinical immunomodulatory signal.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2015 Pharm Biol study described anti-hyperalgesic and anti-inflammatory effects for p-cymene in animal models and linked the signal to opioid-system and cytokine pathways.
A 2015 Pharm Biol study described anti-hyperalgesic and anti-inflammatory effects for p-cymene in animal models and linked the signal to opioid-system and cytokine pathways.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A mitochondrial study found that p-cymene induced proton leak through the Fo portion of ATP synthase, offering a plausible mechanistic explanation for some observed bioenergetic effects.
A mitochondrial study found that p-cymene induced proton leak through the Fo portion of ATP synthase, offering a plausible mechanistic explanation for some observed bioenergetic effects.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
ECHA's harmonized classification page for p-cymene lists Aspiration Hazard 1 (H304) and Aquatic Chronic 2 (H411), which matters more for concentrate handling and formulation than for broad consumer copy.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
The Good Scents safety summary also describes p-cymene as flammable and irritating to eyes, respiratory system, and skin in older European hazard phrasing.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No high-quality human clinical efficacy literature was located for isolated p-cymene, so benefit-style language should stay non-medical and explicitly preclinical.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
alpha-PineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read alpha-Pinene report →gamma-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read gamma-Terpinene report →LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Linalool report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Carvacrol report →alpha-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · antioxidant
No source citation attached.
Read alpha-Terpinene report →ThymolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Thymol report →alpha-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpinene report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read Carvacrol report →LimoneneOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Limonene report →Terpinen-4-olOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Terpinen-4-ol report →alpha-TerpineolNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →CuminaldehydeAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro mechanistic · effect
No source citation attached.
Read Cuminaldehyde report →How the effects were investigated
cytokine modulation
Murine macrophage and rodent inflammation studies suggest p-cymene can reduce pro-inflammatory cytokine signaling in LPS or carrageenan-style models.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
mitochondrial proton leak
A mechanistic membrane-bioenergetics paper reported that p-cymene induced proton leak through the Fo fraction of ATP synthase, altering mitochondrial proton motive force.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- No persuasive human clinical benefit data for isolated p-cymene were located.
- Much of the public bioactivity literature clusters around inflammation and pain models rather than aroma-use outcomes.
- Public safety information is easier to find than controlled dermal-use or inhalation-tolerance studies for isolated p-cymene.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.